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ABSTRACT Rats were given repeated injections of 10 mg/kg of morphine and were
then left undisturbed for 24–25 days before their brains were processed for Golgi-Cox
staining. Prior exposure to morphine decreased the complexity of dendritic branching
and the number of dendritic spines on medium spiny neurons in the shell of the nucleus
accumbens and on pyramidal cells in the prefrontal and parietal cortex. It is suggested
that some of the long-term behavioral consequences of repeated exposure to morphine
may be due to its ability to reorganize patterns of synaptic connectivity in the forebrain.
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The ability of opiates to influence the activity of
ascending catecholamine neurons is thought to contrib-
ute to many of their effects on behavior (Wise and
Bozarth, 1987). Furthermore, when given chronically
opiates induce neuroadaptations in catecholamine sys-
tems, some of which are thought to contribute to the
long-term sequelae associated with repeated opiate use
and abuse, including tolerance, sensitization, depen-
dence, and addiction (Nestler, 1996). Most studies on
opiate-induced neuroadaptations have focused on the
ability of these drugs to alter biochemical processes
and/or the electrophysiological characteristics of neu-
rons. However, we have recently found that repeated
treatment with psychostimulant drugs, such as amphet-
amine or cocaine, alters not only biochemical processes
but also the morphology of cells in brain regions that
are innervated by catecholamine neurons (Robinson
and Kolb, 1997, 1999). Given the similar effects of
psychostimulants and opiates on catecholamine neuro-
transmission, and the increase in illicit opiate use
during the late 1990s (NIDA Monitoring the Future
data; www.nida.nih.gov), we asked whether repeated
exposure to morphine might also alter the morphology
of cells in brain regions innervated by catecholamine
neurons.
Female Sprague-Dawley rats approximately 3 months
old (225–250 g) at the beginning of the experiment
received an i.p. injection of either saline or 10 mg/kg of
morphine sulfate (weight of the salt) once each day for 5
consecutive days, followed by 2 drug-free days, and this
procedure was repeated for 4 weeks. This injection
regimen was used because it has been shown to produce
sensitization to morphine’s psychomotor activating ef-
fects (Jeziorski and White, 1995) and because upon the
discontinuation of drug treatment there are no obvious
overt signs of withdrawal (K.A. Trujillo and F.J. White,
personal communications). After the last injection the
animals were left undisturbed for 24–25 days, after
which time they were deeply anesthetized with sodium
pentobarbital and perfused intracardially with 0.9%
saline. The brains were removed and processed for
Golgi-Cox staining using procedures described previ-
ously (Gibb and Kolb, 1998). Neurons in three brain
regions were selected for analysis: medium spiny neu-
rons in the shell of the nucleus accumbens, layer V
pyramidal cells in the prefrontal cortex (Cg3), and layer
III pyramidal cells in the parietal cortex (Par1; anatomi-
cal terminology after Zilles, 1985). Five cells in each
hemisphere were drawn using camera lucida at a
magnification of 250x by a person blind to treatment
conditions. The dendritic surface was quantified both
by counting the number of branches at each order from
the cell body and by counting the number of ring
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intersections using an overlay of concentric rings (see
Kolb et al., 1998, for details). For cortical cells, the
apical and basilar dendrites were quantified separately.
In addition, the density of dendritic spines was esti-
mated by drawing at least 10 µm long segments from
the terminal tips at high power (1,000x) and counting
the number of spines. Statistical analyses were con-
ducted after averaging across cells within hemispheres
(i.e., hemisphere was the unit of analysis).
In animals treated with morphine there was a marked
decrease in the complexity of dendritic branching and
the density of dendritic spines on neurons in all three
brain regions examined (Figs. 1, 2). There was a 9–19%
decrease in the number of dendritic branches (P , 0.01)
and in three of the five regions a comparable decrease in
dendritic length as estimated by the number of ring
intersections (Fig. 1). There was an especially marked
decrease in the density of dendritic spines in all regions
(P , 0.001), ranging from an 11% loss of spines from
Par1 basilar dendrites to a 29% loss of spines from Cg3
apical dendrites (Fig.1).
If given early during development it is known that
morphine can decrease the complexity of dendrites on
cells in the cerebral cortex and hippocampus (Ricalde
and Hammer, 1990), and because blockade of opioid
receptors can have the opposite effect it is thought that
endogenous opioid systems are important for normal
neuronal development (Hauser et al., 1987, 1989).
However, to our knowledge this is the first report that
repeated exposure to a relatively low dose of morphine
in adult rats can produce a persistent decrease in the
dendritic branching and spine density in the cerebral
cortex and nucleus accumbens. Many studies have
established that changes in dendritic structure seen in
Golgi material, similar to those reported here, are
indicative of alterations in synaptic organization
(Greenough et al., 1990; Kolb et al., 1998). Our results
suggest, therefore, that in adult rats moderate doses of
morphine, not sufficient to produce overt physical depen-
dence, can produce widespread alterations in patterns
of synaptic connectivity in the forebrain, including
brain regions implicated in mediating morphine’s re-
warding effects.
The mechanism by which morphine alters dendritic
structure is not known, but it may be related to its
ability to alter neurofilament proteins or other cytoskel-
etal proteins (Beitner-Johnson et al., 1992; Boronat et
al., 1998). Indeed, it was recently reported that chronic
morphine administration via a subcutaneous implant
produces a 25% decrease in the size of dopamine cell
bodies in the ventral tegmental area (Sklair-Tavron et
al., 1996). In this latter study, nondopaminergic cells in
the ventral tegmental area were unaffected, suggesting
the effects of chronic morphine treatment were highly
localized. The present results suggest, however, that
morphine treatment may in fact promote a widespread
reorganization of synaptic connectivity in the forebrain
Fig. 1. Morphine-induced changes in dendritic morphology. The
three rows proceeding from top to bottom show the mean 6 SEM
number of branches, number of ring intersections (rings), and number
of spines/10 µm, in the shell of the nucleus accumbens (Acc), the
prefrontal cortex (Cg3-A, apical dendrites; Cg3-B, basilar dendrites)
and the parietal cortex (Par1-A and Par1-B, apical and basilar
dendrites, respectively). Where error bars are not evident, they are
smaller than the diameter of the symbol. Open circles (C) indicate the
control group (n 5 10) and closed circles (M) the morphine-treated
group (n 5 10). The control group is the same as reported in Robinson
and Kolb (1999), and all animals were treated and the brains
processed at the same time. Asterisks indicate statistically significant
group differences (t-tests; t-values range from 7.5–423 and P-values
from , 0.01–0.0001), and the numbers above the horizontal axis
indicate the average percent decrease from control.
Fig. 2. Camera lucida drawings of representative nucleus accum-
bens medium spiny neurons (Acc) from a control (top left, C) and
morphine-treated rat (bottom left, M), and prefrontal cortex Layer V
pyramidal cells (Cg3) from a control (middle) and morphine treated rat
(right). Sample dendritic segments used to count spine density are
shown at high power to the right of each cell (the actual segments
represented are indicated by the pointers).
161MORPHINE ALTERS NEURONAL STRUCTURE
(although, of course, there may also be differences in
the neuroadaptive processes engendered by continuous
vs. intermittent morphine treatment; Robinson and
Becker, 1986).
It is especially interesting that the effects of mor-
phine on dendritic structure were in the opposite
direction of those seen in comparable studies with
psychostimulant drugs, and appeared to be more wide-
spread (Robinson and Kolb, 1997, 1999). For example,
repeated amphetamine treatment increased the length
of dendrites on medium spiny neurons in the nucleus
accumbens and the length of apical (but not basilar)
dendrites of pyramidal cells in prefrontal cortex, but
had no effect on the length of either apical or basilar
dendrites of pyramidal cells in the parietal cortex
(Robinson and Kolb, 1997). How the changes in den-
dritic structure produced by either psychostimulants or
morphine alter information processing in these neural
circuits, and thus potentially contribute to the many
long-term functional consequences of repeated expo-
sure to drugs of abuse, including tolerance, sensitiza-
tion, dependence, and addiction, is not known (Nestler,
1996; Sklair-Tavron et al., 1996). Nevertheless, it is
becoming increasingly clear that in exploring the mecha-
nisms by which potentially addictive drugs produce
persistent effects on brain function and behavior it will
be necessary to look beyond brain biochemistry, to
anatomical circuitry (Robinson and Kolb, 1997, 1999;
Sklair-Tavron et al., 1996), as is the case for other forms
of experience-dependent plasticity (Greenough and Bai-
ley, 1988; Harris and Kater, 1994; Kolb et al., 1998).
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